News

Global Strep A vaccine one step closer

Streptococcus genomes reveal potential vaccine targets present in over 20 countries worldwide

Read More

May 28, 2019

By : Team ABLE

The FDA has approved Novartis-subsidiary AveXis Inc's spinal muscular atrophy (SMA) gene therapy Zolgensma.

The company wants to set the price tag at $2,125m per dose.

Read More

May 28, 2019

By : Team ABLE

Health Canada approves Biocon and Mylan’s Ogivri

Ogivri is the first Trastuzumab Biosimilar indicated for the treatment of HER2-positive breast and gastric cancers

Read More

May 24, 2019

By : Team ABLE

Source of disease prevalence information impacts effectiveness of vaccination programs: The Institute of Mathematical Sciences study

The computational modelling of social networks suggests that vaccination programs are more successful in containing disease when individuals have access to local information about disease prevalence.

Read More

May 24, 2019

By : Team ABE

FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies

The FDA granted marketing authorization of the ZIKV Detect 2.0IgM Capture ELISA to InBios International, Inc.

Read More

May 24, 2019

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights